Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis

Bridel, Claire; Killestein, Joep; Teunissen, Charlotte

doi:10.1212/WNL.0000000000200133

Scientific article

Comment

English

Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis

ContributorsBridel, Claire

; Killestein, Joep; Teunissen, Charlotte

Published inNeurology, vol. 98, no. 11, 471

Publication date2022-03-15

Abstract

Comment on

Reader Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis. Kropshofer H, Häring DA, Kappos L, Leppert D, Kuhle J. Neurology. 2022 Mar 15;98(11):470-471. doi: 10.1212/WNL.0000000000200132. PMID: 35288475 No abstract available.

Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis. Bridel C, Leurs CE, van Lierop ZYGJ, van Kempen ZLE, Dekker I, Twaalfhoven HAM, Moraal B, Barkhof F, Uitdehaag BMJ, Killestein J, Teunissen CE. Neurology. 2021 Nov 9;97(19):e1898-e1905. doi: 10.1212/WNL.0000000000012752. Epub 2021 Sep 9. PMID: 34504023. Available: https://archive-ouverte.unige.ch/unige:167344

Keywords

Humans
Immunologic Factors / adverse effects
Intermediate Filaments
Multiple Sclerosis / blood
Multiple Sclerosis, Relapsing-Remitting / blood
Multiple Sclerosis, Relapsing-Remitting / drug therapy
Natalizumab / adverse effects

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département des neurosciences cliniques

Citation (ISO format)

BRIDEL, Claire, KILLESTEIN, Joep, TEUNISSEN, Charlotte. Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis. In: Neurology, 2022, vol. 98, n° 11, p. 471. doi: 10.1212/WNL.0000000000200133

Article (Published version)

Identifiers

PID : unige:167345
DOI : 10.1212/WNL.0000000000200133
PMID : 35288476

Additional URL for this publicationhttps://n.neurology.org/content/98/11/471.1

Journal ISSN0028-3878

153views

51downloads

Creation16/12/2022 07:27:00

First validation16/12/2022 07:27:00

Update time16/03/2023 10:54:18

Status update16/03/2023 10:54:17

Last indexation01/11/2024 04:25:56

Archive ouverte UNIGE

Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis

Technical informations